New llama-derived nanobodies enable selective detection and capture of Z-DNA
New llama-derived nanobodies enable selective detection and capture of Z-DNA
Nielsen, M. I.; Fridy, P. C.; Da Silva, J.; Pourshamsi, M.; Wachsmuth, L.; Kittel, J.; Jiang, H.; Miller, B. D.; Taylor, M. S.; Chait, B. T.; Pasparakis, M.; Kahlenberg, J. M.; Mustelin, T.; Rout, M. P.; LaCava, J.
AbstractZ-DNA is a left-handed DNA conformation that forms transiently at susceptible genomic sequences during processes such as negative supercoiling and active transcription. In the cytoplasm, the innate immune receptor ZBP1 senses Z-form nucleic acids (Z-NAs, which could be DNA or RNA), triggering type I interferon production and programmed cell death. Viral infections, endogenous repetitive-element-derived RNAs, and oxidized mitochondrial DNA can generate Z-NAs, nominating them as ZBP1 agonists. Conversely, ADAR1 is proposed to recognize and edit endogenous Z-RNAs, thereby muting inappropriate innate immune responses. Both proteins engage Z-NAs through Z domains, which are evolutionarily conserved across vertebrates. Progress in defining Z-NA biology has been limited by near-exclusive reliance on the Z22 monoclonal antibody, the field's principal detection reagent. To expand the availability of distinct, validated anti-Z-NA affinity reagents, we generated and characterized llama-derived nanobodies. Llamas were immunized with brominated poly(dG:dC) DNA, and four recombinant nanobodies (nZ6, nZ6.2, nZ10, and nZ11) that bound the antigen were identified through affinity enrichment and mass spectrometry-guided discovery. The nanobodies selectively recognized Z-DNA in biochemical assays and displayed nanomolar affinities, while homodimerized nZ6.2 achieved picomolar binding. Unlike Z domains, nZ6.2 does not induce B-to-Z transitions, indicating recognition of pre-existing Z-DNA and immobilized nZ6.2 selectively co-immunoprecipitated ADAR1 and ZBP1 with Z-DNA but not B-DNA. Furthermore, nZ6.2 detected Z-DNA-related structures in a human keratinocyte cell line and in neutrophils from patients with systemic lupus erythematous, producing staining patterns overlapping those of Z22. These renewable, engineerable binders provide orthogonal reagents for investigating Z-NA biology, interferon signaling, and autoimmune disease.